Veerhealth Care Limited has secured a new sample order worth ₹76.40 lakh from one of India's leading FMCG companies for skincare products. The order is scheduled for execution within 45 days and involves manufacturing goods under a new Maximum Retail Price (MRP) structure designed to facilitate brand promotion and market expansion for the client. This development supports the company's growth trajectory as it targets a total income of ₹105 crores with a PAT of ₹5–6 crores in FY26-27.

The buyer operates in the domestic and international markets within the 'personal and household care' segment and is part of a 125-year-old prominent business group. Veerhealth Care clarified that the promoter, promoter group, or group companies hold no interest in the entity awarding the order, and the transaction does not fall under related party transactions. The disclosure was submitted to BSE Limited on July 23, 2026.

Bhavin S. Shah, Managing Director of Veerhealth Care Limited, signed the regulatory filing. The company highlighted its position as one of India's fastest-growing listed Ayurvedic and cosmetic formulation manufacturers, operating under the brand Ayuveer. Veerhealth Care specializes in manufacturing pure vegetarian toothpaste and is among the few small-cap companies globally to have secured USFDA plant clearance.

Financial Outlook and Strategic Developments

Veerhealth Care provided forward-looking financial guidance, projecting a total income of ₹156 crores with a PAT of ₹9–10 crores in FY27-28. The company reported a book value per share of ₹11.46 for FY26, which is expected to increase substantially following the recent receipt of preferential warrant monies. Additionally, the company is in advanced stages of talks with one of India's largest hotel amenities suppliers, which has an Indo-Canadian joint venture.

Order Details

The following table outlines the key parameters of the order received by Veerhealth Care Limited:

Veerhealth Care has secured a repeat order worth ₹1.11 crore from a leading domestic network of pharmacies and healthcare companies for the supply of haircare and oral care products. The order is valued at ₹1,11,39,950 and must be executed within 45 days. This transaction is classified as a domestic order and does not involve any interest from the promoter, promoter group, or group companies of Veerhealth Care Limited.

Order Details

The buyer operates an extensive chain of hospitals across the country and maintains a nationwide presence. This repeat order underscores the trust placed in the company's capabilities to deliver quality healthcare products. The disclosure was made in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Outlook

The company has provided financial guidance for the upcoming fiscal years. For F.Y. 2026-27, Veerhealth Care expects a Total Income of ₹105 crores with a Profit After Tax (PAT) of minimum ₹5-6 crores. For F.Y. 2027-28, the company anticipates a Total Income of ₹156 crores with a PAT of minimum ₹9-10 crores.

Corporate Actions

The Preferential Issue Committee has approved the allotment of 1,00,00,000 fully convertible warrants. Each warrant carries a right to subscribe to one equity share at an issue price of ₹20.25. Of these, 45,37,000 warrants are contributed by Promoters. The Book Value per share for FY26 is ₹11.46, which is expected to increase substantially with the infusion of funds from these warrants.

Key Order Information